Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Deciphering Effects of Thalidomide on Red Blood Cells in Transfusion Dependents Beta Thalassemia Patients: A Pharmacodynamics and Pharmacogenetics Analysis

NCT06146478 is registered in ClinicalTrials.gov with Blood Care Clinic as lead sponsor.

NCT NCT06146478
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06146478 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Deciphering Effects of Thalidomide on Red Blood Cells in Transfusion Dependents Beta Thalassemia Patients: A Pharmacodynamics and Pharmacogenetics Analysis
Lead sponsor
Blood Care Clinic
Phase
Phase 3
Overall status
Completed
Start date
January 25, 2022
Completion date
October 31, 2023
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

transfusion-dependent beta-thalassemia